# 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy

> **NCT02196480** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 27 (actual)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **BIOLOGICAL:** anti-TNF

## Key facts

- **NCT ID:** NCT02196480
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-06
- **Final completion:** 2012-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196480, "23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02196480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*